Potential Serological Use of a Recombinant Protein That Is a Replica of a Mycobacterium tuberculosis Protein Found in the Urine of Infected Mice

Clinical and Diagnostic Laboratory Immunology

Volumn 11, Issue 2, 2004, Pages 280-286

  Mukherjee, Sandeep ^a   Daifalla, Nada ^a   Zhang, Yanni ^b   Douglass, John ^b   Brooks, Lisa ^b   Vedvick, Thomas ^b   Houghton, Raymond ^b   Reed, Steven G ^a,b   Campos Neto, Antonio ^a,c  

^a INFECTIOUS DISEASE RESEARCH INSTITUTE   (United States)

^b GLAXOSMITHKLINE   (United States)

^c FORSYTH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; URINE PROTEIN 1; URINE PROTEIN 1 ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; BACTERIAL GROWTH; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNE RESPONSE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SEROLOGY; SERUM; SIGNAL DETECTION; URINE;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; CLONING, MOLECULAR; HIV INFECTIONS; HUMANS; MICE; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS, PULMONARY;

EID: 1642292400     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.11.2.280-286.2004     Document Type: Article

References (35)

1. American Thoracic Society. 1981. The tuberculin skin test. Am. Rev. Respir. Dis. 124:356-363.
2. American Thoracic Society and Centers for Disease Control. 1991. Diagnostic standards and classification of tuberculosis. Am. Rev. Respir. Dis. 142:725-735.
3. Bothamley, G. H. 1995. Serological diagnosis of tuberculosis. Eur. Respir. J. Suppl. 20:676s-688s.
4. Brusasca, P. N., R. Colangeli, K. P. Lyashchenko, X. Zhao, M. Vogelstein, J. S. Spencer, D. N. McMurray, and M. L. Gennaro. 2001. Immunological characterization of antigens encoded by the RD1 region of the Mycobacterium tuberculosis genome. Scand. J. Immunol. 54:448-452.
5. Campos-Neto, A., V. Rodrigues-Junior, D. B. Pedral-Sampaio, E. M. Netto, P. J. Ovendale, R. N. Coler, Y. A. Skeiky, R. Badaro, and S. G. Reed. 2001. Evaluation of DPPD, a single recombinant Mycobacterium tuberculosis protein as an alternative antigen for the Mantoux test. Tuberculosis (Edinburgh) 81:353-358.
6. Campos-Neto, A., L. Soong, J. L. Cordova, D. Sant'Angelo, Y. A. W. Skeiky, N. H. Ruddle, S. G. Reed, Jr., C. A. Janeway, and D. McMahon-Pratt. 1999. Cloning and expression of a Leishmania donovani instructed by a peptide isolated from major histocompatibility complex class 11 molecules of infected macrophages. J. Exp. Med. 182:1423-1433.
7. Chan, E. D., L. Heifets, and M. D. Iseman. 2000. Immunologic diagnosis of tuberculosis: a review. Tuber. Lung Dis. 80:131-140.
8. Chiang, I. H., J. Suo, K. J. Bai, T. P. Lin, K. T. Luh, C. J. Yu, and P. C. Yang. 1997. Serodiagnosis of tuberculosis. A study comparing three specific mycobacterial antigens. Am. J. Respir. Crit. Care Med. 156:906-911.
9. Coler, R. N., Y. A. Skeiky, P. J. Ovendale, T. S. Vedvick, L. Gervassi, J. Guderian, S. Jen, S. G. Reed, and A. Campos-Neto. 2000. Cloning of a Mycobacterium tuberculosis gene encoding a purified protein derivative protein that elicits strong tuberculosis-specific delayed-type hypersensitivity. J. Infect. Dis. 182:224-233.
10. Dillon, D. C., M. R. Alderson, C. H. Day, T. Bement, A. Campos-Neto, Y. A. Skeiky, T. Vedvick, R. Badaro, S. G. Reed, and R. Houghton. 2000. Molecular and immunological characterization of Mycobacterium tuberculosis CFP-10, an immunodiagnostic antigen missing in Mycobacterium bovis BCG. J. Clin. Microbiol. 38:3285-3290.
11. Dye, C., S. Scheele, P. Dolin, V. Pathania, and M. C. Raviglione. 1999. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 282:677-686.
12. Espitia, C., I. Cervera, R. Gonzalez, and R. Mancilla. 1989. A 38-kD Mycobacterium tuberculosis antigen associated with infection. Its isolation and serologic evaluation. Clin. Exp. Immunol. 77:373-377.
13. Ginsberg, A. M. 1998. The tuberculosis epidemic. Scientific challenges and opportunities. Public Health Rep. 113:128-136.
14. Gupta, S., R. Bhatia, and K. K. Datta. 1995. Serodiagnosis of tuberculosis. J. Commun. Dis. 27:208-214.
15. Gupta, S., S. Kumari, J. N. Banwalikar, and S. K. Gupta. 1995. Diagnostic utility of the estimation of mycobacterial antigen A60 specific immunoglobulins IgM, IgA and IgG in the sera of cases of adult human tuberculosis. Tuber. Lung Dis. 76:418-424.
16. Gygi, S. P., G. L. Corthals, Y. Zhang, Y. Rochon, and R. Aebersold. 2000. Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology. Proc. Natl. Acad. Sci. USA 97:9390-9395.
17. Haas, F., and S. S. Haas. 1996. The origins of Mycobacterium tuberculosis and the notion of its contagiousness, p. 3-19. In W. R. Rom and S. M. Garay (ed.), Tuberculosis. Little, Brown & Company, Boston, Mass.
18. Hendrickson, R. C., J. F. Douglass, L. D. Reynolds, P. D. McNeill, D. Carter, S. G. Reed, and R. L. Houghton. 2000. Mass spectrometric identification of mtb81, a novel serological marker for tuberculosis. J. Clin. Microbiol. 38:2354-2361.
19. Hopewell, P. C. 1992. Impact of human immunodeficient virus infection on the epidemiology, clinical features, management and control of tuberculosis. Clin. Infect. Dis. 18:540-547.
20. Houghton, R. L., M. J. Lodes, D. C. Dillon, L. D. Reynolds, C. H. Day, P. D. McNeill, R. C. Hendrickson, Y. A. Skeiky, D. P. Sampaio, R. Badaro, K. P. Lyashchenko, and S. G. Reed. 2002. Use of multiepitope polyproteins in serodiagnosis of active tuberculosis. Clin. Diagn. Lab. Immunol. 9:883-891.
21. Huebner, R. E., M. F. Schein, and J. B. Bass, Jr. 1993. The tuberculin skin test. Clin. Infect. Dis. 17:968-975.
22. Kochi, A. 1991. The global tuberculosis situation and the control strategy of the World Health Organization. Tubercle 72:1-6.
23. Lodes, M. J., D. C. Dillon, R. Mohamath, C. H. Day, D. R. Benson, L. D. Reynolds, P. McNeill, D. P. Sampaio, Y. A. Skeiky, R. Badaro, D. H. Persing, S. G. Reed, and R. L. Houghton. 2001. Serological expression cloning and immunological evaluation of MTB48, a novel Mycobacterium tuberculosis antigen. J. Clin. Microbiol. 39:2485-2493.
24. Mantoux, M. C. 1912. La vioe intradermique en tuberculinatherapie. Presse Med. 20:146-148.
25. Moran, A. J., J. D. Treit, J. L. Whitney, B. Abomoelak, R. Houghton, Y. A. Skeiky, D. P. Sampaio, R. Badaro, and F. E. Nano. 2001. Assessment of the serodiagnostic potential of nine novel proteins from Mycobacterium tuberculosis. FEMS Microbiol. Lett. 198:31-36.
26. Netto, E. M., C. Dye, and M. C. Raviglione. 1999. Progress in global tuberculosis control 1995-1996, with emphasis on 22 high-incidence countries. Global Monitoring and Surveillance Project. Int. J. Tuberc. Lung Dis. 3:310-320.
27. Okwera, A., C. Whalen, F. Byekwaso, M. Vjecha, J. Johnson, R. Huebner, R. Mugerwa, and J. Ellner. 1994. Randomised trial of thiacetazone and rifampicin-containing regimens for pulmonary tuberculosis in HIV-infected Ugandans. The Makerere University-Case Western University Research Collaboration. Lancet 344:1323-1328.
28. Orme, I. M. 1987. The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis. J. Immunol. 138:293-298.
29. Raja, A., U. D. Ranganathan, R. Bethunaickan, and V. Dharmalingam. 2001. Serologic response to a secreted and a cytosolic antigen of Mycobacterium tuberculosis in childhood tuberculosis. Pediatr. Infect. Dis. J. 20:1161-1164.
30. Raviglione, M. C., J. P. Narain, and A. Kochi. 1992. HIV-associated tuberculosis in developing countries: clinical features, diagnosis and treatment. Bull. W. H. O. 70:515-526.
31. Raviglione, M. C., D. E. Snider, Jr., and A. Kochi. 1995. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA 273:220-226.
32. Sudre, P., G. ten Dam, and A. Kochi. 1992. Tuberculosis: a global overview of the situation today. Bull. W. H. O. 70:149-159.
33. Wilkinson, R. J., K. Haslov, R. Rappuoli, F. Giovannoni, P. R. Narayanan, C. R. Desai, H. M. Vordermeier, J. Paulsen, G. Pasvol, J. Ivanyi, and M. Singh. 1997. Evaluation of the recombinant 38-kilodalton antigen of Mycobacterium tuberculosis as a potential immunodiagnostic reagent. J. Clin. Microbiol. 35:553-557.
34. World Health Organization. 1994. The current global situation of the HIV/AIDS pandemic. Wkly. Epidemiol. Rec. 69:191-192.
35. Yates, J. R., III, J. K. Eng, A. L. McCormack, and D. Schieltz. 1995. Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database. Anal. Chem. 67:1426-1436.